Jump to main content.


Human Exposure to Environmental Contaminants

Human Health Icon
Human Health Chapter


Chapter Leader
  • Danelle Lobdell
    Office of Research and Development

  • roe@epa.gov
Chapters

What are the trends in exposure to environmental contaminants including across population subgroups and geographic regions?

Understanding the extent to which human populations are being exposed to environmental contaminants helps identify those contaminants of potential public health concern and populations who may be disproportionately exposed to contaminants or uniquely vulnerable. For example, children may have disproportionately heavy exposures to environmental contaminants because they drink more water, breathe more air, and eat more food per pound or kilogram of body weight than adults; further, children may be more vulnerable to some environmental contaminants depending on the stage of development during which exposure occurs.3,4 Evaluating exposure across certain race or ethnic groups, or other potentially susceptible subgroups, identifies possible variations in exposures. Tracking the levels of environmental contaminants in a population also enables an assessment of how exposures to those contaminants are changing in that population over time.

Referring back to the environmental public health paradigm presented in Section 5.1.1, measurements of human exposure to environmental contaminants can be made in the ambient environment (air, water, land), at the point of human contact, or after contact and contaminant entry into the human body has occurred. Box 5-1 further distinguishes the different types of exposure measures. In answering this question, the focus is on human biomonitoring, which involves the measurement of human tissues or excreta for direct or indirect evidence of exposure to chemical, biological, or radiological substances. The ambient contaminant measurements presented in the media chapters are not considered here, nor can they be directly linked with biomonitoring data presented to answer this question.

Box 5-1. Measuring Human Exposure

Various approaches can be used to measure or estimate the levels of human exposures. No approach is best suited to all environmental contaminants, and each approach has strengths and weaknesses. Available biomonitoring data are used to answer the question on trends in human exposure to environmental contaminants.

Ambient contaminant measurements: Historically, human exposures have been estimated using environmental measurements of ambient contaminant concentrations. One limitation of ambient measurements is that the presence of a contaminant in the environment may not be fully informative regarding the extent to which individuals are exposed. In some cases, emissions data are used to model or estimate ambient concentrations.

Models of exposure: This approach combines knowledge of environmental contaminant concentrations with information on people's activities and locations (e.g., time spent working, exercising outdoors, sleeping, shopping) to account for the contact with contaminants. This approach requires knowledge of contaminant levels where people live, work, and play, as well as knowledge of their day-to-day activities. Since model output is not a direct measure of environmental conditions or exposure, it is not considered to be a true indicator of exposure.

Personal monitoring data: With personal monitoring, the monitoring device is worn by individuals as they engage in their normal day-to-day activities. This approach is most commonly used in workplace environments. Personal monitoring data provide valuable insights into the source of contaminants to which people are actually being exposed. However, a challenge with personal monitoring (as with biomonitoring) is ensuring that sufficient sampling is conducted to be representative of the population being studied. No national-scale personal monitoring data are available.

Biomonitoring data: Several environmental contaminants, notably heavy metals and some pesticides and other persistent organic pollutants, can accumulate in the body. These substances or their metabolites can be measured in human tissues or fluids such as blood or urine. These residues reflect the amount of contaminant that gets into or is present in the body, but by themselves do not provide information on how the person came into contact with the contaminant.

Historically, human exposure has been defined as the amount of a chemical, physical, or biological contaminant at the outer boundary of the body available for exchange or intake via inhalation, ingestion, or skin or eye contact.5 As such, human exposure to environmental contaminants has been estimated primarily through measurements of contaminant concentrations in air, water, or soil, combined with estimates of the frequency and duration of human contact with the contaminated media. These resulting exposure estimates have provided a valuable foundation for many of the regulatory and non-regulatory actions that have been taken to limit exposure to ambient contaminants. However, developments in data collection techniques and analytical methods have improved the capability to characterize human exposure via biomonitoring, which provides measurements of contaminants within the human body.

For a few environmental contaminants, particularly lead and some other metals, biomonitoring has been used for exposure characterization for a number of years. More recently, techniques for biomonitoring have been expanded to include many additional environmental contaminants. These measurements provide a tool that complements ambient measurements in characterizing human exposure to environmental contaminants. However, concentrations of environmental contaminants reported at a national level in blood, urine, or any other type of tissue cannot be used to extrapolate directly to a particular source.

The use of biological markers (or biomarkers) builds on the more traditional exposure assessment approach, providing more information on the extent to which a contaminant enters, remains, and acts in the body. Biomarker information attempts to determine the extent to which a contaminant is present in the body after entering through portals of entry such as the eyes, skin, stomach, intestines, or lungs. Given the complex set of factors that govern contaminants that are absorbed and distributed in the body, a direct measurement of the levels of a contaminant or related “marker” in the body offers more information about exposure than measured ambient levels alone.

In general, a biomarker reports the level of a substance or a marker (i.e., the product of an interaction between an agent and some target molecule or cell) present in samples collected from the body or produced by the body. Biomarkers of exposure measure concentrations of a contaminant, its metabolite(s), or reaction product(s) in the body fluids or tissue, most commonly blood or urine. Measurements can also be taken from a variety of other body compartments, such as feces, breast milk, hair, nails, exhaled air, and tissues obtained through biopsy or autopsy. The exposure measure used to answer this question focuses on biomarkers of exposure. Biomarkers of exposure do not predict whether biological alterations and potential health effect will result. Whether a particular exposure ultimately results in an adverse health outcome depends on a host of factors, as is described in Section 5.1.

Top of Page


Local Navigation


Jump to main content.